A
Arrivent Biopharma Inc
NASDAQ:AVBP
Arrivent Biopharma Inc
NASDAQ:AVBP
Price:
22.02
USD
-3.67%
Market Closed
Market Cap:
$909m
Income Statement
Earnings Waterfall
Arrivent Biopharma Inc
Arrivent Biopharma Inc
Income Statement
Arrivent Biopharma Inc
Arrivent Biopharma Inc
Currency: USD
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(62)
|
(75)
|
(95)
|
(86)
|
(94)
|
(94)
|
(140)
|
(148)
|
(162)
|
(178)
|
|
| Selling, General & Administrative |
(8)
|
(10)
|
(13)
|
(13)
|
(15)
|
(15)
|
(17)
|
(19)
|
(21)
|
(24)
|
|
| Research & Development |
(54)
|
(65)
|
(82)
|
(73)
|
(79)
|
(79)
|
(123)
|
(129)
|
(141)
|
(153)
|
|
| Operating Income |
(62)
N/A
|
(75)
-20%
|
(95)
-28%
|
(86)
+10%
|
(94)
-9%
|
(94)
-1%
|
(140)
-49%
|
(148)
-6%
|
(162)
-9%
|
(178)
-9%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
3
|
5
|
9
|
11
|
13
|
14
|
13
|
11
|
11
|
11
|
|
| Pre-Tax Income |
(59)
N/A
|
(69)
-18%
|
(87)
-25%
|
(75)
+14%
|
(81)
-8%
|
(80)
+1%
|
(127)
-58%
|
(137)
-7%
|
(151)
-11%
|
(166)
-10%
|
|
| Net Income | |||||||||||
| Income from Continuing Operations |
(59)
|
(69)
|
(87)
|
(75)
|
(81)
|
(80)
|
(127)
|
(137)
|
(151)
|
(166)
|
|
| Net Income (Common) |
(59)
N/A
|
(69)
-18%
|
(87)
-25%
|
(75)
+14%
|
(81)
-8%
|
(80)
+1%
|
(127)
-58%
|
(137)
-7%
|
(151)
-11%
|
(166)
-10%
|
|
| EPS (Diluted) |
-1.84
N/A
|
-2.17
-18%
|
-3.46
-59%
|
-2.23
+36%
|
-2.41
-8%
|
-2.56
-6%
|
-3.78
-48%
|
-3.91
-3%
|
-3.61
+8%
|
-4.32
-20%
|
|
Switch to:
Switch to:
See Also
Discover More
